Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Heisler, M. Hogan, T. Hofer, J. Schmittdiel, M. Pladevall, E. Kerr (2008)
When More Is Not Better: Treatment Intensification Among Hypertensive Patients With Poor Medication AdherenceCirculation, 117
R. Schmieder (2010)
The Role of Fixed-Dose Combination Therapy with Drugs that Target the Renin-Angiotensin System in the Hypertension ParadigmClinical and Experimental Hypertension, 32
L Liu (2011)
2010 Chinese guidelines for the management of hypertensionChin J Cardiol., 39
E. Okonofua, K. Simpson, Ammar Jesri, S. Rehman, V. Durkalski, B. Egan (2006)
Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control GoalsHypertension, 47
I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cífková, J. Dallongeville, G. Backer, S. Ebrahim, B. Gjelsvik, C. Herrmann-Lingen, A. Hoes, Stephen Humphries, M. Knapton, J. Perk, S. Priori, K. Pyôrâlà, Ž. Reiner, L. Ruilope, Susana Sans-Menendez, W. Reimer, P. Weissberg, D. Wood, J. Yarnell, Luis Jose (2007)
Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)European Journal of Cardiovascular Prevention & Rehabilitation, 14
L. Vark, M. Bertrand, K. Akkerhuis, J. Brugts, K. Fox, J. Mourad, E. Boersma (2012)
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158 998 patientsEuropean Heart Journal, 33
A. Dragomir, R. Cote, L. Roy, L. Blais, L. Lalonde, A. Bérard, S. Perreault (2010)
Impact of Adherence to Antihypertensive Agents on Clinical Outcomes and Hospitalization CostsMedical Care, 48
T. Bramley, B. Nightengale, F. Frech‐Tamas, Phillip Gerbino (2006)
Relationship of Blood Pressure Control to Adherence With Antihypertensive Monotherapy in 13 Managed Care OrganizationsJournal of Managed Care Pharmacy : JMCP, 12
N. Beckett, R. Peters, A. Fletcher, J. Staessen, Li-sheng Liu, D. Dumitrascu, V. Stoyanovsky, R. Antikainen, Y. Nikitin, C. Anderson, A. Belhani, F. Forette, C. Rajkumar, L. Thijs, W. Banya, C. Bulpitt (2008)
Treatment of hypertension in patients 80 years of age or older.The New England journal of medicine, 358 18
Peng Chen, Sandip Chaugai, Fujie Zhao, Daowen Wang (2015)
Cardioprotective Effect of Thiazide-Like Diuretics: A Meta-Analysis.American journal of hypertension, 28 12
G. Savarese, P. Costanzo, J. Cleland, E. Vassallo, Donatella Ruggiero, G. Rosano, P. Perrone-filardi (2013)
A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure.Journal of the American College of Cardiology, 61 2
Li-sheng Liu (2011)
[2010 Chinese guidelines for the management of hypertension].Zhonghua xin xue guan bing za zhi, 39 7
G. Mancia, G. Backer, A. Dominiczak, R. Cífková, R. Fagard, G. Germano, G. Grassi, A. Heagerty, S. Kjeldsen, S. Laurent, K. Narkiewicz, L. Ruilope, A. Rynkiewicz, R. Schmieder, H. Boudier, A. Zanchetti (2007)
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Journal of Hypertension, 25
B. Dahlöf, P. Sever, N. Poulter, H. Wedel, D. Beevers, M. Caulfield, R. Collins, S. Kjeldsen, A. Kristinsson, G. Mcinnes, J. Mehlsen, M. Nieminen, E. O’Brien, J. Östergren (2005)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled triThe Lancet, 366
(2010)
All-Russian Scientific Society of Cardiologists (VNOK)
Ajay Gupta, S. Arshad, N. Poulter (2010)
Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents: A Meta-AnalysisHypertension, 55
G. Boysen (2009)
European Guidelines on Cardiovascular Disease PreventionInternational Journal of Stroke, 4
G. Roush, M. Ernst, J. Kostis, S. Tandon, D. Sica (2015)
Head-to-Head Comparisons of Hydrochlorothiazide With Indapamide and Chlorthalidone: Antihypertensive and Metabolic EffectsHypertension, 65
J. Perk, G. Backer, H. Gohlke, I. Graham, eljko Reiner, Monique Verschuren, C. Albus, P. Benlian, G. Boysen, R. Cífková, C. Deaton, S. Ebrahim, Miles Fisher, G. Germano, R. Hobbs, A. Hoes, Ş. Karadeniz, A. Mezzani, E. Prescott, L. Rydén, M. Scherer, M. Syvänne, W. Reimer, C. Vrints, D. Wood, J. Zamorano, F. Zannad (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)European Journal of Preventive Cardiology, 19
J. Chalmers, H. Arima, M. Woodward, G. Mancia, N. Poulter, Y. Hirakawa, S. Zoungas, Anushka Patel, B. Williams, S. Harrap (2014)
Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus: Results From the Action in Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) TrialHypertension, 63
A. Gradman (2010)
Rationale for Triple‐Combination Therapy for Management of High Blood PressureThe Journal of Clinical Hypertension, 12
Mvb Malachias, W. Souza, Frida Plavnik, Cis Rodrigues, Andréa Brandão, Mft Neves, L. Bortolotto, Rjs Franco, Cep Figueiredo, Pcbv Jardim, C. Amodeo, E. Barbosa, V. Koch, M. Gomes, RB Paula, R. Póvoa, Fc Colombo, S. Filho, R. Miranda, C. Machado, F. Nobre, A. Nogueira, D. Júnior, S. Kaiser, C. Forjaz, Fa Almeida, Jfv Martim, N. Sass, Lf Drager, E. Muxfeldt, Lc Bodanese, Ad Feitosa, D. Malta, Sandra Fuchs, M. Magalhães, W. Oigman, O. Gomes, Amg Pierin, Gs Feitosa, M. Bortolotto, Lbnc Magalhães, Acsd Silva, Jm Ribeiro, Fao Borelli, M. Gus, O. Júnior, J. Toledo, Gf Salles, Lc Martins, Tsv Jardim, Icb Guimarães, Ic Antonello, E. Júnior, V. Matsudo, G. Silva, L. Costa, A. Alessi, Lcn Scala, E. Coelho, D. Souza, Hf Lopes, Mmg Gowdak, A. Júnior, Torloni, Mrst Klein, Pk Nogueira, Lad Lotaif, Gba Rosito, H. Junior (2016)
7ª Diretriz Brasileira de Hipertensão Arterial: Capítulo 14 – Crise HipertensivaArquivos Brasileiros De Cardiologia, 107
Michael Weber, E. Schiffrin, W. White, S. Mann, L. Lindholm, J. Kenerson, J. Flack, B. Carter, B. Materson, C. Ram, D. Cohen, Jean-Claude Cadet, Roger Jean-Charles, S. Taler, D. Kountz, R. Townsend, J. Chalmers, Agustín Ramírez, G. Bakris, Jiguang Wang, A. Schutte, J. Bisognano, R. Touyz, D. Sica, S. Harrap (2014)
Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension.Journal of hypertension, 32 1
(2010)
All-Russian Scientific Society of Cardiologists (VNOK). Diagnosis and treatment of arterial hypertensionSystemnye Hypertensii., 3
J. Basile, J. Neutel (2010)
Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapyTherapeutic Advances in Cardiovascular Disease, 4
A. Tykarski, Krzysztof Narkiewicz, Zbigniew Gaciong, A. Januszewicz, M. Litwin, Katarzyna Kostka-Jeziorny (2015)
Guidelines for the Management of HypertensionArterial Hypertension, 19
J. Neutel, David Smith (2013)
Hypertension management: rationale for triple therapy based on mechanisms of action.Cardiovascular therapeutics, 31 5
W. Elliott (2010)
Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 TrialsYearbook of Cardiology, 2010
MF Piepoli, AW Hoes, S Agewall (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Eur Heart J
D. Calhoun, Nora Crikelair, J. Yen, R. Glazer (2009)
Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safetyAdvances in Therapy, 26
M. Strauss, A. Hall (2016)
The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death.Progress in cardiovascular diseases, 58 5
HR Black (2009)
Triple fixed-dose combination therapyBack to the past. Hypertension, 54
N. Chung, S. Baek, M.‐F. Chen, C. Liau, C. Park, J. Park, T. Saruta, K. Shimamoto, Z. Wu, J. Zhu, T. Fujita (2008)
Expert recommendations on the challenges of hypertension in AsiaInternational Journal of Clinical Practice, 62
A. Leung, K. Nerenberg, S. Daskalopoulou, K. McBrien, K. Zarnke, K. Dasgupta, L. Cloutier, M. Gelfer, M. Lamarre-Cliche, A. Milot, P. Bolli, G. Tremblay, D. Mclean, S. Tobe, M. Ruzicka, K. Burns, M. Vallée, G. Prasad, M. Lebel, R. Feldman, P. Selby, A. Pipe, E. Schiffrin, P. McFarlane, P. Oh, R. Hegele, Milan Khara, T. Wilson, S. Penner, E. Burgess, R. Herman, S. Bacon, S. Rabkin, R. Gilbert, T. Campbell, S. Grover, G. Honos, P. Lindsay, M. Hill, S. Coutts, G. Gubitz, N. Campbell, G. Moe, J. Howlett, J. Boulanger, Ally Prebtani, P. Larochelle, L. Leiter, Charlotte Jones, R. Ogilvie, V. Woo, J. Kaczorowski, L. Trudeau, R. Petrella, S. Hiremath, D. Drouin, K. Lavoie, P. Hamet, G. Fodor, J. Grégoire, R. Lewanczuk, G. Dresser, Mukul Sharma, Debra Reid, S. Lear, G. Moullec, M. Gupta, L. Magee, A. Logan, K. Harris, J. Dionne, A. Fournier, G. Benoît, J. Feber, L. Poirier, R. Padwal, D. Rabi (2016)
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.The Canadian journal of cardiology, 32 5
Harikrishna Makani, S. Bangalore, Jorge Romero, O. Wever-Pinzon, F. Messerli (2011)
Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema.The American journal of medicine, 124 2
Anushka Patel (2007)
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialThe Lancet, 370
C. Furberg, J. Wright, B. Davis, J. Cutler, M. Alderman, H. Black, W. Cushman, R. Grimm, L. Haywood, F. Leenen, S. Oparil, J. Probstfield, P. Whelton, C. Nwachuku, D. Gordon, M. Proschan, Paula Einhom, C. Ford, L. Piller, I. Dunn, D. Goff, S. Pressel, Judy Bettencourt, Barbara DeLeon, Lara Simpson, J. Blanton, T. Geraci, Sandra Walsh, C. Nelson, Mahboob Rahman, Anne Juratovac, R. Pospíšil, L. Carroll, Sheila Sullivan, J. Russo, G. Barone, Rudy Christian, S. Feldman, T. Lucente, D. Calhoun, Kimo Jenkins, Peggy McDowell, Janice Johnson, C. Kingry, J. Alzate, K. Margolis, Leslie Holland-Klemme, B. Jaeger, J. Williamson, G. Louis, Pamela Ragusa, A. Williard, R. Ferguson, J. Tanner, J. Eckfeldt, R. Crow, J. Pelosi (2002)
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).JAMA, 288 23
G. Mazzaglia, E. Ambrosioni, M. Alacqua, A. Filippi, E. Sessa, V. Immordino, C. Borghi, O. Brignoli, A. Caputi, C. Cricelli, L. Mantovani (2009)
Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive PatientsCirculation, 120
S. Julius, S. Kjeldsen, M. Weber, H. Brunner, S. Ekman, L. Hansson, T. Hua, J. Laragh, G. Mcinnes, Lada Mitchell, F. Plat, A. Schork, Beverly Smith, A. Zanchetti (2004)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialThe Lancet, 363
A. Sierra (2009)
Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin–angiotensin systemJournal of Human Hypertension, 23
(2015)
Polish Society of Hypertension, et al. 2015 guidelines for the management of hypertension. Recommendations of the Polish Society of Hypertension
K. Tóth, O. investigators (2014)
Antihypertensive Efficacy of Triple Combination Perindopril/Indapamide Plus Amlodipine in High-Risk Hypertensives: Results of the PIANIST Study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients)American Journal of Cardiovascular Drugs, 14
S. Bangalore, G. Kamalakkannan, S. Parkar, F. Messerli (2007)
Fixed-dose combinations improve medication compliance: a meta-analysis.The American journal of medicine, 120 8
M. Piepoli, A. Hoes, S. Agewall, C. Albus, C. Brotons, A. Catapano, M. Cooney, U. Corrà, B. Cosyns, Christi Deaton, I. Graham, Michael Hall, F. Hobbs, M. Løchen, H. Löllgen, P. Marques-Vidal, J. Perk, E. Prescott, J. Redón, D. Richter, N. Sattar, Y. Smulders, M. Tiberi, H. Worp, I. Dis, W. Verschuren (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice.Revista espanola de cardiologia, 69 10
G. Mancia, G. Backer, A. Dominiczak, R. Cífková, R. Fagard, G. Germano, G. Grassi, A. Heagerty, S. Kjeldsen, S. Laurent, K. Narkiewicz, L. Ruilope, A. Rynkiewicz, R. Schmieder, H. Boudier, A. Zanchetti, A. Vahanian, J. Camm, R. Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S. Kristensen, K. Mcgregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. Zamorano, S. Erdine, W. Kiowski, E. Agabiti-Rosei, E. Ambrosioni, L. Lindholm, G. Mancia, A. Manolis, P. Nilsson, J. Redón, H. Struijker-Boudier, M. Viigimaa, S. Adamopoulos, V. Bertoméu, D. Clement, C. Farsang, D. Gaita, G. Lip, J. Mallion, A. Manolis, E. O’Brien, P. Ponikowski, F. Ruschitzka, J. Tamargo, P. Zwieten, B. Waeber, B. Williams, The hype (2007)
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).European heart journal, 28 12
PA James (2014)
507JAMA, 311
MA Weber (2014)
3J Hypertens, 32
F. Messerli, Harikrishna Makani, A. Benjo, Jorge Romero, C. Alviar, S. Bangalore (2011)
Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials.Journal of the American College of Cardiology, 57 5
W. Remme, J. McMurray, F. Hobbs, A. Cohen-Solal, J. López-Sendón, A. Boccanelli, F. Zannad, B. Rauch, Karen Keukelaar, C. Macarie, W. Rużyłło, C. Cline (2008)
Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians.European heart journal, 29 14
E. Yiannakopoulou, J. Papadopulos, D. Cokkinos, T. Mountokalakis (2005)
Adherence to antihypertensive treatment: a critical factor for blood pressure controlEuropean Journal of Preventive Cardiology, 12
P. James, S. Oparil, B. Carter, W. Cushman, C. Dennison-Himmelfarb, J. Handler, D. Lackland, M. LeFevre, T. Mackenzie, O. Ogedegbe, Sidney Smith, L. Svetkey, S. Taler, R. Townsend, J. Wright, A. Narva, E. Ortiz (2014)
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).JAMA, 311 5
(2011)
NICE-Clinical Guidelines Hypertension: the clinical management of primary hypertension in adults-NCGC (National Clinical Guideline Centre) 127
EC Yiannakopoulou, JS Papadopulos, DV Cokkinos (2005)
Adherence to antihypertensive treatment: a critical factor for blood pressure controlEur J Cardiovasc Prev Rehabil., 12
G. Mancia, R. Fagard, K. Narkiewicz, J. Redón, A. Zanchetti, M. Böhm, T. Christiaens, R. Cífková, G. Backer, A. Dominiczak, M. Galderisi, D. Grobbee, T. Jaarsma, P. Kirchhof, S. Kjeldsen, S. Laurent, A. Manolis, P. Nilsson, L. Ruilope, R. Schmieder, P. Sirnes, P. Sleight, M. Viigimaa, B. Waeber, F. Zannad (2007)
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).Journal of hypertension, 31 7
G Mancia (2013)
1281J Hypertens, 31
K. Jamerson, G. Bakris, B. Dahlöf, B. Pitt, E. Velazquez, Jitendra Gupte, M. Lefkowitz, A. Hester, V. Shi, S. Kjeldsen, W. Cushman, V. Papademetriou, M. Weber (2007)
Exceptional early blood pressure control rates: The ACCOMPLISH trialBlood Pressure, 16
S. Daskalopoulou, D. Rabi, K. Zarnke, K. Dasgupta, K. Nerenberg, L. Cloutier, M. Gelfer, M. Lamarre-Cliche, A. Milot, P. Bolli, D. McKay, G. Tremblay, D. Mclean, S. Tobe, M. Ruzicka, K. Burns, M. Vallée, G. Prasad, M. Lebel, R. Feldman, P. Selby, A. Pipe, E. Schiffrin, P. McFarlane, P. Oh, R. Hegele, Milan Khara, T. Wilson, S. Penner, E. Burgess, R. Herman, S. Bacon, S. Rabkin, R. Gilbert, T. Campbell, S. Grover, G. Honos, P. Lindsay, M. Hill, S. Coutts, G. Gubitz, N. Campbell, G. Moe, J. Howlett, J. Boulanger, Ally Prebtani, P. Larochelle, Lawrence Leiter, Charlotte Jones, R. Ogilvie, V. Woo, J. Kaczorowski, L. Trudeau, R. Petrella, S. Hiremath, J. Stone, D. Drouin, K. Lavoie, P. Hamet, G. Fodor, J. Grégoire, A. Fournier, R. Lewanczuk, G. Dresser, Mukul Sharma, Debra Reid, G. Benoît, J. Feber, K. Harris, L. Poirier, R. Padwal (2013)
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.The Canadian journal of cardiology, 31 5
(2016)
Sociedade Brasileira de Cardiologia (SBC). 7a Diretriz Brasileira de Hipertensão Arterial
R. Ferrari, G. Rosano (2013)
Not just numbers, but years of science: putting the ACE inhibitor-ARB meta-analyses into context.International journal of cardiology, 166 2
G. Savarese, P. Costanzo, J. Cleland, E. Vassallo, Donatella Ruggiero, G. Rosano, P. Perrone-filardi (2013)
A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURERacionalʹnaâ Farmakoterapiâ v Kardiologii, 9
D. Johnston (2001)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attackThe Lancet, 358
S. Oparil, M. Melino, James Lee, Victor Fernandez, R. Heyrman (2010)
Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.Clinical therapeutics, 32 7
F. Elijovich, Cheryl Laffer (2009)
A role for single-pill triple therapy in hypertensionTherapeutic Advances in Cardiovascular Disease, 3
R. Fogari, A. Zoppi, F. Tettamanti, G. Malamani, C. Tinelli, A. Salvetti (1992)
Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study.Journal of cardiovascular pharmacology, 19 5
DS Wald, M Law, JK Morris, JP Bestwick, NJ Wald (2009)
Combination therapy vs. monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trialsAm J Med, 122
H. Black (2009)
Triple fixed-dose combination therapy: back to the past.Hypertension, 54 1
Cardiol Ther (2017) 6:91–104 DOI 10.1007/s40119-017-0085-7 ORIGINAL RESEARCH Single-Pill Combination of Perindopril/Indapamide/ Amlodipine in Patients with Uncontrolled Hypertension: A Randomized Controlled Trial Sergey V. Nedogoda Vesna J. Stojanov Received: October 13, 2016 / Published online: February 8, 2017 The Author(s) 2017. This article is published with open access at Springerlink.com (SBP C140 and \160 mmHg and DBP C90 ABSTRACT and\100 mmHg), uncontrolled on maximal dose antihypertensive monotherapy or with a Introduction: Patients with hypertension often single dose of dual therapy. Patients were ran- require a combination of three antihypertensive domly assigned to: single-pill triple combina- agents to achieve blood pressure control, but tion of perindopril 5 mg/indapamide 1.25 mg/ very few single-pill triple combinations are amlodipine 5 mg (Per/Ind/Aml) or dual-pill available. The aim of this study was to deter- combination perindopril 5 mg/indapamide mine whether a single-pill triple combination of 1.25 mg ? amlodipine 5 mg (Per/Ind ? Aml) perindopril, indapamide, and amlodipine was once daily for 12 weeks. The primary endpoint as effective as a dual-pill combination of was change in office supine SBP and DBP from perindopril/indapamide plus separate amlodip- baseline to week 12. The proportion of respon- ine at reducing blood pressure in patients with
Cardiology and Therapy – Springer Journals
Published: Feb 8, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.